Alembic Gets USFDA Approval for Generic Deep Vein Thrombosis Medication
August 13, 2024 16:54
Alembic Pharmaceuticals receives USFDA approval for its generic Dabigatran Etexilate Capsules (110 mg) for deep vein thrombosis and pulmonary embolism prophylaxis.